Wedbush Cuts Earnings Estimates for Travere Therapeutics
Travere Therapeutics, Inc. (NASDAQ:TVTX – Free Report) – Equities research analysts at Wedbush reduced their Q4 2025 earnings estimates for shares of Travere Therapeutics in a research report issued on Monday, February 24th. Wedbush analyst L. Chico now anticipates that the company will post earnings of $0.12 per share for the quarter, down from their […]
Travere Therapeutics, Inc. (NASDAQ:TVTX – Free Report) – Equities research analysts at Wedbush reduced their Q4 2025 earnings estimates for shares of Travere Therapeutics in a research report issued on Monday, February 24th. Wedbush analyst L. Chico now anticipates that the company will post earnings of $0.12 per share for the quarter, down from their […]
